2009

Capital Royalty Purchases Interest in Royalty Portfolio

In the fourth quarter of 2009, a global pharmaceutical company sold a royalty interest in two leading drugs targeting different therapeutic areas to a consortium of investors (including Capital Royalty) for more than $100 million.

2009

Capital Royalty Purchases Royalty Bonds

Through a series of acquisitions in the second quarter of 2009, Capital Royalty purchased more than $30 million of royalty bonds from several financial institutions.